Poison Center Exposures to Bootleg Retatrutide Nearly Double in Three Months as FDA Logs Two Death Reports

4,000 Brigham and Women’s Nurses Postpone Wednesday Strike to Vote on Hospital’s Best and Final Contract OfferBrigham and Women’s nurses postponed the Oct. 14 strike to vote on a final offer. See the pay, insurance, and staffing terms, and what patients face. Parents Should Check Amazon Bath Seats and Dressers, Giant Bike Lock Keys, and Avengers Medals in New RecallsNew CPSC recalls cover Amazon baby bath seats and dressers, Giant LED bike lock keys, and Avengers medals. See what you own and how to get refunds. Chicago Marathon’s Record Field of More Than 55,000 Faces a Yellow-Flag Day with Highs Near 71 DegreesThe Chicago Marathon starts under a yellow flag with a forecast high near 71, above the 65-degree normal. Heat illness signs and when to stop. Records Detail Immediate Jeopardy Citation After Charlotte Nursing Home Resident in Wheelchair Was Fatally Struck in 2023Records show inspectors cited a Charlotte nursing home at the immediate jeopardy level after a resident in a wheelchair was fatally struck on a busy road. Mental Health The Brain’s So-Called Christmas Spirit Network Lit Up in 10 Holiday Lovers, but Red Pictures Might Explain ItAn fMRI study found five brain regions responded more to Christmas images in people who celebrate, but the authors admitted red may be to blame. Frequent Mental Distress in Adults 18 to 29 Climbed From 12.7% to 21.3% Since 2012 Despite Recent DeclinesCDC data show 1 in 5 adults 18 to 29 report frequent mental distress, up from 2012 but down two years straight. Where to find help today. A Strong Smell Could Set Off His Sneezing Fits, but His Muscles Told a Stranger StoryStrong smells set off a teacher’s sneeze-like fits for nine years. Muscle recordings showed rapid jerks unlike a textbook sneeze reflex. Louisiana Finds New Synthetic Opioid Cychlorphine in at Least Two Deaths, Warns Extra Naloxone Doses May Be NeededLouisiana found cychlorphine in at least two overdose deaths since December 2025. See where the opioid has spread and why naloxone may need repeating. Innovation AI Chatbots Failed to Urge Emergency Care in About 41% of Vietnamese Scenarios Versus 15% in EnglishA simulated test presented at ACG 2026 found that AI chatbots missed urgent GI warnings far more often in Vietnamese. What families should know. AI Tool Helped Neurology Residents Tell Epilepsy From Functional Seizures Correctly Up to 89% of the TimeA University of Minnesota AI tool reads clinical notes to help doctors tell epilepsy from functional seizures. What it found and why it isn’t ready. A Medical Paper Called a 37-Year-Old Study Recent, and Nearly 1 in 5 Recent Citations Were at Least a Decade OldA BMJ analysis of 1,000 papers found 17.7% of references labeled recent were at least 10 years old, and some dated back as far as 37 years. No Measles, Mumps or Chickenpox Cases Followed Accidental Live Vaccines in 220 IBD Patients on Immune-Modifying DrugsNo measles, mumps, or chickenpox cases followed accidental live vaccine administration in 220 IBD patients on immunosuppressive drugs. Why live shots are still avoided. Healthy Living Isaias Outages Left Gulf Coast Fridges Warm for Days: Which Groceries to Toss and Which to KeepAfter Isaias, Gulf Coast families face costly fridge decisions. See which foods USDA charts say to toss, which can stay, and where help may exist. Only 40% of Americans Have Strong Confidence in Hospitals and Clinics While 52% Trust Science a LotNew Wellcome data show Americans trust science more than most nations but doubt hospitals. What patients say drives the gap and what can help. San Francisco Expands Doxy-PEP to Women and Others as Officials Report 24% Drop in Syphilis CasesSan Francisco now offers the after-sex antibiotic doxy-PEP to more people as syphilis and chlamydia rates fall. What it is, who qualifies, and the risks. Queens Pharmacy Owner Arrested Trying to Board One-Way Toronto Flight in Alleged $31 Million HIV Medicaid FraudA Jackson Heights pharmacy owner faces fraud charges over HIV drug kickbacks and buybacks. What patients and taxpayers need to know about the case. Covid – 19 FDA Proposes Requiring Companies to Report Food Additives That Now Reach Grocery Shelves Without Federal ReviewFDA has released its proposed GRAS rule requiring companies to notify the agency about food additives. Here is what the proposal does and does not do. Federal Regulators Warn Some Hair Dryer Brushes Lack the Part That Stops ElectrocutionCPSC warns hair dryer brushes sold on Walmart.com and TikTok Shop lack immersion protection. The seller has not agreed to a recall or refund. A Recalled Teething Toy Broke the Pattern Parents Were Told to Look ForA newly recalled pull-string teething toy has a different model number and design from earlier recalls, and one choking incident has been reported. Trying to Lower Blood Sugar, Cholesterol or Blood Pressure? Different Workouts Suited Different MarkersA pooled analysis of 53 trials found that different exercise types helped different metabolic markers. Most of the evidence was low certainty. YAMIL LAGE | AFP via Getty Images Share on Twitter Share on Facebook Share on Pocket America’s Poison Centers logged 862 exposures to retatrutide in the three months ending in September, up from 460 in the prior three months and 249 in the first three months of 2026, CBS News reported. The FDA has also received two reports of people who died after taking products sold as retatrutide, an experimental Eli Lilly obesity drug that no regulator has approved.

Whether the drug caused either death has not been established. The reports were filed through the FDA’s Adverse Event Reporting System, and the agency declined to say whether it had verified them. CBS said it could not independently verify the reports either. Still, the figures raise a pressing question for adults buying injectable “peptides” online, often through wellness sites, med spas, or social media links, without a prescription or medical oversight.

The first report, filed in July by a health care professional, describes a 41-year-old woman with obesity who went into cardiac arrest after using retatrutide obtained from an unreliable source. She arrived at a hospital with a dangerously fast heartbeat and died after repeated attempts to resuscitate her failed. The report noted that she had also been drinking kava, a plant-based relaxant.

The second, received in September, describes a 49-year-old patient who died after severe dehydration, malnutrition, and cardiac arrest. According to the report, a nurse recommended the drug, sold her vials from an online peptide vendor, and gave her dosing recommendations. A vial pictured in the report carried the name of a peptide seller. An attorney for that company said there was not enough information to link it to the product and that the vial did not match its current packaging. “A licensed healthcare professional should never recommend research-use-only products to a patient,” the attorney added.

Adverse event reports are early warning signals, not proof. Anyone can file one, details are often incomplete, and the FDA redacted identifying information in the copies CBS obtained through a Freedom of Information Act request. Neither death was connected to a clinical trial, according to the documents and Lilly.

Pieter Cohen, an associate professor at Harvard Medical School, told CBS, “It is concerning because of the breakdown of our drug-approval process in the United States of America.” He said the FDA should obtain and test the products the patients injected. The FDA said it reviews adverse event reports and gathers more information when needed, but it generally does not discuss potential or ongoing compliance matters.

The retatrutide studied by Lilly is not the same as what is sold online. In the phase 3 TRIUMPH-1 trial of 2,339 adults, participants on the highest dose lost an average of 28.3% of their body weight over 80 weeks under medical supervision, Lilly reported in its trial announcement. Participants in that trial were screened, started at lower doses, and were monitored regularly.

Those results come from company-funded research, and regulators have not yet reviewed the drug. Lilly says authentic retatrutide is available only through its clinical trials and a limited expanded access program, and it plans to submit the drug to the FDA in early 2027, Becker’s Hospital Review reported. The company has referred more than 200 people and businesses to regulators, law enforcement, and licensing boards.

Lilly told CBS that suspect products it tested contained too much, too little, or the wrong active ingredient, along with contaminants. In August, Lilly sued six companies over alleged retatrutide sales, accusing them of using “research use only” labels while selling the products to people for injection. Those allegations have not been decided in court.

A June Public Citizen investigation found that the FDA had sent 14 warning letters to companies selling retatrutide since 2024, yet eight of those companies were still selling it as of May. The consumer advocacy group also counted 14 reported hospitalizations tied to retatrutide in the FDA’s adverse event system and described hundreds of influencers acting as sales affiliates. “The era of snake oil and quack medicine is back,” said Peter Whoriskey, research director of Public Citizen’s Health Research Group.

In Lilly’s trial, the most common side effects at the highest dose were gastrointestinal, including nausea, diarrhea, constipation, and vomiting. Severe vomiting or diarrhea can lead to dangerous fluid loss. Products of unknown strength make those risks harder to predict; contaminated vials can carry infection risks of their own, and people injecting without a clinician have no one monitoring how they respond. Sharing vials or reusing needles adds further danger.

Anyone who has used a gray-market product should tell a clinician and keep the vial and packaging. Questions about a possible reaction can go to Poison Help at 1-800-222-1222, which connects callers to America’s Poison Centers. Chest pain, fainting, a racing heartbeat, nonstop vomiting, severe belly pain, or signs of dehydration need emergency care right away.

People should not stop or change prescribed medications without medical advice. Cost often drives gray-market buying, so patients can ask a clinician about FDA-approved weight-loss drugs, insurance coverage, prior authorization appeals, and manufacturer savings programs. Patients and clinicians can report suspected reactions through FDA MedWatch.

Lilly’s FDA submission, any agency review of the death reports, and the next quarterly poison center tally will show whether the trend is slowing. Until then, the tested drug remains promising, and the products sold online remain unverified. MedicalDaily will continue monitoring both.

What is retatrutide? Retatrutide is an experimental injectable obesity drug developed by Eli Lilly. No regulator has approved it, and authentic retatrutide is available only through Lilly’s clinical trials and a limited expanded access program.

Did retatrutide cause the two deaths? That has not been established. The reports were submitted to an FDA database that collects unverified safety signals, and the agency has not said whether it confirmed the details.

How fast are poison center exposures rising? Poison centers logged 862 exposures from July through September, compared with 460 in the prior three months and 249 in the first three months of 2026.

Is it legal to buy retatrutide online? No retatrutide product is approved for human use. Sellers often label vials “research use only,” which Lilly argues in court is a cover for sales to consumers.

What symptoms need urgent care? Seek emergency care for chest pain, fainting, a racing heartbeat, severe or nonstop vomiting, intense belly pain, or signs of dehydration such as dizziness and very little urine.

Where can I get help if I used a gray-market product? Call Poison Help at 1-800-222-1222 and speak with a clinician. Keep the vial and packaging so the product can be identified if needed.